Edwards Lifesciences Enters Into Agreement To Acquire CASMED

IRVINE, Calif. and BRANFORD, Conn. , Feb. 12, 2019 /PRNewswire/ —  Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has entered into a definitive merger agreement to

Original Source